Blood clots in the legs or lungs (deep vein thrombosis or pulmonary embolism) kill an American about every 5 minutes. Adopting seven simple lifestyle steps could help reduce your risk of these potentially deadly blood clots, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology 2013 Scientific Sessions.
In a large, long-term study, researchers followed 30,239 adults who were 45 years or older for 4.6 years. Researchers rated participants' heart health using the seven health indicators from the American Heart Association Life's Simple 7. They include being physically active, avoiding smoking, following a healthy diet, maintaining a healthy body mass index, and controlling blood sugar levels, blood pressure and cholesterol. They then compared the incidence of blood clots among those whose heart health rated as inadequate, average and optimum.
Among participants with optimum health, the risk of blood clots was 44 percent lower than those with inadequate health. Those with average health had a 38 percent lower risk. Maintaining ideal levels of physical activity and body mass index were the most significant lifestyle changes related to lower risk of blood clots.
Note: Actual presentation is 5:30 p.m. ET Wednesday, May 2, 2013.
Follow news from the American Heart Association's ATVB Conference 2013 via Twitter @HeartNews; #ATVB13.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.